Dec. 22, 2004 — The U.S. Food and Drug Administration (FDA) approved in October revisions to drug safety labeling to advise healthcare professionals of the following changes: use of the multidose ...
Lovenox (enoxaparin) is a prescription drug used to prevent or treat certain types of blood clots. Lovenox’s cost may depend on factors such as your dosage, whether you have health insurance, and how ...
The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis (DVT), a ...
CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated generic injectables company today announced the launch of Enoxaparin Sodium Injection, USP, the generic ...
Syringe marking errors, which can lead to incorrect dosing, caused a recall of Enoxaparin Sodium Injection, a generic version of blood clot medication Lovenox. The recall issued Tuesday by Apotex, a ...
Sandoz is the first company to receive US approval to market a more affordable generic version of the leading hospital-based medication in the US US 2009 sales of Lovenox® were USD 2.7 billion ...
PARSIPPANY, N.J., Oct. 8, 2011 /PRNewswire via COMTEX/ -- Watson Pharmaceuticals, Inc. today confirmed that the United States District Court for the District of Massachusetts has granted a request by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback